Tests a supplement mix against a placebo in children with autism
Compares a bee-product and plant supplement mix with a placebo in children with autism.
Plain-language title generated from the registry record
Registry title: Combination of Supplements for Treating Autistic Spectrum Disorder
Key facts
- Where
- Bucharest and Constanța, RomaniaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 14 years old?
Source: NCT06756711, who can take part
Where in Romania
- Clinica Aide SanteBucharest, RomaniaNo longer taking part
- Medical Link SRLConstanța, RomaniaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundatia Bio-Forum
- Trial code
- NCT06756711
- Record updated
- 3 January 2025
- Original description
A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.Read full original descriptionShow less
Combination of Supplements for Treating Autistic Spectrum Disorder
A pilot study to compare the efficacy of a combination of apitherapy supplements versus placebo in children with autistic spectrum disorder.
Inclusion: age 3-14 years; diagnosed with typical or atypical autism spectrum disorder (F84.0 or F84.1) and received at least one therapeutic intervention before enrolling; the ability to follow an oral treatment, with TID/BID/QD administration; the availability to perform 3 sets of blood tests at a clinical laboratory within 6 months (initial, at 3- and 6-months); the availability to perform 3 visits to the Investigator and 3 psychometric evaluations within 6 months.
Exclusion: patients enrolled in another interventional clinical trial currently or which ended less than 1 month prior to enrolling in this study; administration of anticoagulants, antiplatelets, thrombolytic agents, low molecular weight heparins, anticonvulsants, insulin, monoamine oxidase inhibitors, non-steroidal anti-inflammatory drugs or thiazide diuretics; known allergy to hive products or one of the substances studied; diagnosis of diabetes; history of seizures/epilepsy; allergy to celery and other plants of the Fam. Apiaceaea (Umbelliferae); inability to perform the study requirements (3 visits to the Investigator, 3 psychometric assessments, 3 sets of blood tests); abnormally elevated baseline (at V1) values of ferritin, homocysteine, HgbA1c, ESR.